Clinical Evidence Supporting the Use of CAPLYTA for Adults With Bipolar Depression: Bipolar I or II in Monotherapy and Adjunctive Therapy Clinical Studies
Wednesday, February 23, 2022, 7:00-8:00 p.m.
Featuring Amber R. Hoberg, APN, Psychiatric Mental Health Nurse Practitioner, GeroPsych Associates of Central Texas
CAPLYTA is indicated in adults for the treatment of schizophrenia and depressive episodes associated with bipolar I or II disorder (bipolar depression), as monotherapy and as adjunctive therapy with lithium or valproate.
Amber R. Hoberg, APN, is a psychiatric mental health nurse practitioner at GeroPsych Associates of Central Texas in Austin. Ms Hoberg earned her master’s degree in nursing as a psychiatric mental health nurse practitioner from the University of Texas Health Science Center at San Antonio. She is a member of the Sigma Theta Tau Honor Society. Ms Hoberg is certified by the American Nurses Credentialing Center as a family psychiatric mental health nurse practitioner.
AAPPN thanks Intra-Cellular Therapies for being an exhibitor at our 2021 Conference!